Skip to main content

Table 4 Survival analysis for cases of mucinous carcinoma with expansile invasion and high-grade serous carcinoma

From: Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis

 

Progression-free survival

Overall survival

 

Univariate analysis

Multivariate analysis

Univariate analysis

Multivariate analysis

Variables

HR (95% CI)

p-value

HR (95% CI)

p-value

HR (95% CI)

p-Value

HR (95% CI)

p-value

Age (years)

            

≥60 vs. <60

1.28

(0.92–1.76)

0.14

   

1.21

(0.82–1.78)

0.34

   

FIGO stage

            

I vs. II, III, IV

0.16

(0.07–0.30)

<0.01

0.28

(0.12–0.61)

<0.01

0.05

(0.01–0.17)

<0.01

0.10

(0.01–0.34)

<0.01

Residual tumor at PDS

            

Yes vs. No

2.26

(1.57–3.33)

<0.01

1.17

(0.78–1.79)

0.46

2.61

(1.67–4.24)

<0.01

1.15

(0.73–1.91)

0.56

Histological subtype

            

MC with expansile invasion vs. HGSC

0.08

(0.01–0.24)

<0.01

0.17

(0.03–0.58)

<0.01

0.06

(0.003–0.25)

<0.01

0.18

(0.01–0.86)

0.03

  1. Abbreviations
  2. HR, hazard ratio; CI, confidence interval; FIGO, International Federation of Obstetrics and Gynecology; PDS, primary debulking surgery; MC, mucinous carcinoma; HGSC, high-grade serous carcinoma